Catch up with all of the past week's GUV news.
H1 2015 data review: a tale of two quarters
An analysis of GUV data for the year so far.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Queensland startups receive $17.8m jolt
Queensland startups receive AU$24m state-backed boost as part of AU$180m Advance Queensland initiative.
Imperial Innovations extends its account at EIB
Imperial Innovations takes out further £50m debt facility with European Investment Bank.
Haemostatix impresses Royal Society of Chemistry
Leicester spinout Haemostatix wins £20,000 prize from Royal Society of Chemistry for bleeding control technology.
Fingerhut abruptly leaves Cleveland Clinic
Gary Fingerhut departs from Cleveland Clinic Innovations amidst investigation into one of its spinouts.
IQE computes Cardiff on joint venture
Cardiff University teams with IQE on joint venture to lead commercialisation of compound semiconductor technologies.
Oxford partners Ludwig on immunotherapy
Isis Innovation and Ludwig Cancer Research join forces on immunotherapy spinout iOx Therapeutics.
Tsinghua puts all chips on Micron with $23bn bid
Tsinghua Unigroup lays out potential $23bn bid for chip maker Micron in potentially the largest acquisition of a US company by a Chinese firm ever.
Eligo’s surgical strikes on bacteria net €2m
MIT and Rockefeller spin-out Eligo Bioscience raises €2m to commercialise precise antibiotics.
Fanduel wins series E battle with $275m
Google, Time Warner, Turner Sports, NBC and Comcast all participated in a round that valued the fantasy sports operator at more than $1bn.
Autifony successfully sounds out investors for series A extension
The GlaxoSmithKline spin-out, which is working on treatments for hearing disorders, has raised additional funds to extend the Pfizer-backed round to $36.6m.
Siemens subscribes to HTGF’s Magazino stake
Siemens Novel Businesses has acquired the stake in automated robotics developer Magazino held by High-Tech Gruenderfonds.
